Last reviewed · How we verify
Linolic Acid (LINOLEIC ACID)
At a glance
| Generic name | LINOLEIC ACID |
|---|---|
| Target | Aldo-keto reductase family 1 member C3, Fatty acid-binding protein, adipocyte, Fatty acid-binding protein, heart |
| Modality | Small molecule |
| Therapeutic area | Metabolic |
| Phase | FDA-approved |
Approved indications
Common side effects
Key clinical trials
- Search for Biological Markers of Orosensory Perception of Fatty Acids in Healthy Subjects and Possible Modifications in Patients With Type 2 Diabetes and in Obese Non-diabetic Patients. (NA)
- Metabolic Effects of Linoleic Acid-Rich Oil Compared to a Blend Oil in Adults With Insulin Resistance (NA)
- Dietary Oil to Improve Sleep Quality (NA)
- Fatty Acid Supplementation in Children With ASD (Study 2) (PHASE2)
- Efficacy of Diet on Quality of Life in Multiple Sclerosis (NA)
- Effects of Adjunct Omega-3 Long Chain Polyunsaturated Fatty Acids in Pulmonary Tuberculosis Patient: an Early Bactericidal Activity and Inflammatory Trial (PHASE2)
- The Healthy Cookie Study: Understanding How Healthy Cookies Affect Fat in the Blood, (NA)
- The Impact of Pumpkin Seed Oil Supplementation on Hemodialysis Patients (NA)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Linolic Acid CI brief — competitive landscape report
- Linolic Acid updates RSS · CI watch RSS